Page 554 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 554

542        FLUID THERAPY



                 long-term captopril therapy in severe chronic heart failure.  136. Riegger GA, Liebau G, Kochsiek K. Antidiuretic hormone
                 Ann Intern Med 1986;104:147–54.                     in congestive heart failure. Am J Med 1982;72:49–52.
            119. Packer M, McMurray J, Massie BM, et al. Clinical effects  137. Riegger GA, Liebau G, Holzschuh M, et al. Role of the
                 of endothelin receptor antagonism with bosentan in  renin-angiotensin system in the development of congestive
                 patients with severe chronic heart failure: results of a pilot  heart failure in the dog as assessed by chronic converting-
                 study. J Card Fail 2005;11:12–20.                   enzyme blockade. Am J Cardiol 1984;53:614–8.
            120. Packer M, Medina N, Yshak M. Correction of dilutional  138. Ritz E, Nowack R. Detrimental and beneficial effects of
                 hyponatremia in severe chronic heart failure by     converting enzyme inhibitors on the kidney. J Cardiol
                 converting-enzyme  inhibition.  Ann  Intern  Med    Pharmacol 1990;16(Suppl. 4):570–5.
                 1984;100:782–9.                                 139. Roche BM, Schwartz D, Lehnhard RA, et al. Changes in
            121. Packer M. Neurohumoral interactions and adaptations in  concentrations  of  neuroendocrine  hormones  and
                 congestive heart failure. Am J Cardiol 1985;55:1A–10A.  catecholamines in dogs with myocardial failure induced
            122. Paradiso G, Bakris GL, Stein JH. The kidney and heart  by rapid ventricular pacing. Am J Vet Res 2003;63:1413–7.
                 failure. In: McCall D, Rahimtoola SH, editors. Heart fail-  140. Rose BD, Post TW. Clinical physiology of acid base and
                 ure. New York: Chapman & Hall; 1995. p. 135–58.     electrolyte disorders. 5th ed New York: McGraw Hill;
            123. Parmley WW. Pathophysiology of congestive heart failure.  2001. p. 702.
                 Am J Cardiol 1985;55:9A–14A.                    141. Rose BD, Post TW. Clinical physiology of acid base and
            124. Patak RV, Fadem SZ, Rosenblatt SG, et al. Diuretic-  electrolyte disorders. 5th ed New York: McGraw Hill;
                 induced changes in renal blood flow and prostaglandin  2001. p. 677.
                 E excretion in the dog. Am J Physiol 1979;236:  142. Rose BD. Diuretics. Kidney Int 1991;39:336–52.
                 F494–F500.                                      143. Roudebush P, Allen TA, Kuehn NF, et al. The effect of
            125. Pedersen HD, Koch J, Poulsen K, et al. Activation of the  combined therapy with captopril, furosemide, and a
                 renin-angiotensin system in dogs with asymptomatic and  sodium-restricted  diet  on  serum  electrolyte
                 mildly symptomatic mitral valvular insufficiency. J Vet  concentrations and renal function in normal dogs and
                 Intern Med 1995;9:328–31.                           dogs with congestive heart failure. J Vet Intern Med
            126. Pedersen HD, Schutt T, Sondergaard R, et al. Decreased  1994;8:337–42.
                 plasma concentration of nitric oxide metabolites in dogs  144. Rush JE, Freeman LM, Brown DJ, et al. Clinical, echocar-
                 with untreated mitral regurgitation. J Vet Intern Med  diographic, and neurohormonal effects of a sodium-
                 2003;17:178–84.                                     restricted diet in dogs with heart failure. J Vet Intern
            127. Pedersen HD. Effects of mild mitral-valve insufficiency,  Med 2000;14:513–20.
                 sodium-intake, and place of blood-sampling on the  145. Rush JE, Freeman LM, Brown DJ, et al. The use of enal-
                 renin-angiotensin system in dogs. Acta Vet Scand    april in the treatment of feline hypertrophic cardiomyop-
                 1996;37:109–18.                                     athy. J Am Anim Hosp Assoc 1998;34:38–41.
            128. Pion PD, Kittleson MD. Therapy for feline aortic throm-  146. Ryan MP. Diuretics and potassium/magnesium deple-
                 boembolism. In: Kirk RW, editor. Current veterinary ther-  tion: directions for treatment. Am J Med 1987;82(Suppl.
                 apy X. Philadelphia: WB Saunders; 1989. p. 295–301.  3A):38–47.
            129. Pitt B, Zannad F, Remme WJ, et al. The randomized  147. Sabbah HN, Sharov VG, Gupta RC, et al. Chronic therapy
                 aldactone evaluation study investigators: the effect of  with metoprolol attenuates cardiomyocyte apoptosis
                 spironolactone on morbidity and mortality in patients with  in dogs with heart failure. J Am Coll Cardiol
                 severe heart failure. N Engl J Med 1999;341:709–17.  2000;36:1698–705.
            130. Pouchelon JL. (for the Benazepril in Canine Heart Dis-  148. Sabbah HN, Shimoyama H, Kono T, et al. Effects of long-
                 ease Study Group (BENCH). The effect of benazepril  term monotherapy with enalapril, metoprolol, and
                 on survival times and clinical signs of dogs with congestive  digoxin on the progression of left ventricular dysfunction
                 heart failure: results of the multicenter, prospective,  and dilation in dogs with reduced ejection fraction.
                 randomized, double-blind, placebo-controlled, long term  Circulation 1994;89:2852–9.
                 clinical trial. J Vet Cardiol 1999;1:7–18.      149. Sayer  MB,  Atkins  CE,  Fujii  Y,  Adams  AK,
            131. Priebe H, Heimann JC, Hedley-Whyte J. Effects of renal  DeFrancesco TC, Keene BW. Acute effect of pimobendan
                 and hepatic venous congestion on renal function in the  and furosemide on the circulating renin-angiotensin-aldo-
                 presence of low and normal cardiac output in dogs. Circ  sterone system in healthy dogs. J Vet Intern Med 2009;23
                 Res 1980;47:883–90.                                 (5):1003–6.
            132. Prosek R, Sisson DD, Oyama MA, et al. Plasma endothelin-  150. Schrier RW, Abraham WT. Hormones and hemodynamics
                 1 immunoreactivity in normal dogs and dogs with acquired  in heart failure. N Engl J Med 1999;341:577–85.
                 heart disease. J Vet Intern Med 2004;18:840–4.  151. Schrier RW, Humphreys MH, Ufferman RC. Role of car-
            133. Prosek R, Sisson DD, Oyama MA, Solter PF.           diac output and the autonomic nervous system in the
                 Distinguishing cardiac and noncardiac dyspnea in 48 dogs  antinatriuretic response to acute constriction of the
                 using plasma atrial natriuretic factor, B-type natriuretic  thoracic superior vena cava. Circ Res 1971;29:490–8.
                 factor, endothelin, and cardiac troponin-I. J Vet Intern  152. Schrier RW. Pathogenesis of sodium and water retention
                 Med 2007;21(2):238–42.                              in high output and low output cardiac failure, nephrotic
            134. Reinhardt HW, Kaczmarczy KG, Eisele R, et al. Left atrial  syndrome, cirrhosis and pregnancy. N Engl J Med
                 pressure and sodium balance in conscious dogs on a low  1988;319:1065–72 1127–1134.
                 sodium intake. Pflugers Arch 1977;370:59–66.    153. Seely JF, Dirks JH. Site of action of diuretic drugs. Kidney
            135. Riegger GA, Elsner D, Kroner EP, et al. Atrial natriuretic  Int 1977;11:1–8.
                 peptide in congestive heart failure in the dog: plasma  154. Shimoyama H, Sabbah HN, Rosman H, et al. Effects of
                 levels, cyclic guanidine monophosphate, ultrastructure  long-term therapy with enalapril on severity of functional
                 of atrial myoendocrine cells, and hemodynamic, hor-  mitral regurgitation in dogs with moderate heart failure.
                 monal, and renal effects. Circulation 1988;77:398–406.  J Am Coll Cardiol 1995;25:768–72.
   549   550   551   552   553   554   555   556   557   558   559